Shandong Weigao Group Medical Polymer Company Limited reported that, for the month ended 31 May 2026, it repurchased 3.87 million H-shares on the Hong Kong market, spending an estimated HKD 13.25 million at prices ranging from HKD 3.32 to HKD 3.56 per share.
Authorised capital unchanged • Authorised share capital remained at RMB 457.06 million, comprising 4.52 billion H-shares and 48.30 million non-listed shares, each with a par value of RMB 0.10.
Issued and treasury shares • Issued H-shares (excluding treasury shares) declined to 4.46 billion from 4.47 billion at the end of April. • Treasury shares increased to 57.69 million, or approximately 1.3 % of the total issued share capital. • Total issued shares, inclusive of treasury stock, stayed at 4.52 billion.
Public float The company confirmed that public float met the Main Board’s 25 % minimum requirement as at 31 May 2026.
Repurchase details Nineteen on-market transactions were executed between 4 May and 29 May 2026, with individual deal sizes ranging from 62,000 to 690,000 shares. The weighted average repurchase price stood at roughly HKD 3.43 per share.
Comments